China Biologic Products Inc news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

CBPO 55.95 +1.27 (2.32%)
price chart
China Biologic Products Becomes Oversold (CBPO)
In trading on Monday, shares of China Biologic Products Inc (NASD: CBPO) entered into oversold territory, hitting an RSI reading of 29.1, after changing hands as low as $49.11 per share.
Related articles »  
Hot Stock List: China Biologic Products (CBPO), Fiesta Restaurant Group, Inc ...
China Biologic Products (NASD:CBPO) CFO Ming Yang sold 6,164 shares of China Biologic Products stock in a transaction dated Monday, September 15th.
China Biologic Receives Approval for Commercial Manufacturing of Human ...
BEIJING, China I October 17, 2014 I China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has received ...
Related articles »  
China Biologic Products VP Unloads $132516 in Stock (CBPO)
China Biologic Products Inc logo China Biologic Products (NASDAQ:CBPO) VP Gang Cbpo Yang unloaded 2,454 shares of China Biologic Products stock in a transaction dated Monday, September 15th.
China Biologic Products VP Ming Yin Sells 3073 Shares (CBPO)
China Biologic Products Inc logo China Biologic Products (NASDAQ:CBPO) VP Ming Yin unloaded 3,073 shares of the stock in a transaction that occurred on Friday, September 12th.
Related articles »  
Stocks to Watch : Zogenix, Inc. (NASDAQ:ZGNX), Morgan Stanley (NYSE:MS ...
On October 17, China Biologic Products, Inc. (NASDAQ:CBPO) shares increased 4.91% and was closed at $54.67. CBPO EPS growth in last 5 year was 28.50 announced that the Company has received approval from the China Food and Drug Administration ...
Trending Tickers: Legacy Reserves LP (NASDAQ:LGCY), China Biologic ...
China Biologic Products, Inc. (NASDAQ:CBPO) VP Gang Cbpo Yang unloaded 2,454 shares of China Biologic Products stock in a transaction dated Monday, September 15th.
Related articles »  
Watch List: EMCORE Corporation (NASDAQ:EMKR), General Electric Company ...
China Biologic Products, Inc. (NASDAQ:CBPO), a leading fully integrated plasma-based biopharmaceutical company in China, on 17 October announced that the Company has received approval from the China Food and Drug Administration (the �CFDA�) for ...
Related articles »  
A Chinese Biopharmaceutical Company Under The Radar
China Biologic Products has been riding on the rapid growth of the Chinese economy and the aging of the domestic population, which has turned China into the world's third largest medicine market, behind only America and Japan. From 2008 to 2013, ...
Hottest Healthcare Stocks Now - CLVS CELG ACAD CBPO
Clovis Oncology Inc (CLVS): CLVS stock is up 3.3%, marking the ninth consecutive day the stock has increased. Celgene Corp (CELG): CELG stock is up 2.8% today.